Volume 2, Issue 3 (Spring 2024)                   CPR 2024, 2(3): 183-186 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Banihashem S, Motazedian S, Yasamy M, Shamsi A, Kheradmand A, Pirsalehi A, et al . Identifying Anxiety-related Physical Factors in Adult Patients With COVID-19 Hospitalized Based on the National Clinical Guideline: A Prospective Cross-sectional Study. CPR 2024; 2 (3) :183-186
URL: http://cpr.mazums.ac.ir/article-1-108-en.html
Department of Psychosomatic Medicine, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. & Research Development Committee, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:   (441 Views)

Background and Objective: This study aimed to investigate the underlying causes of anxiety in patients with COVID-19 according to the “anxiety management guideline in inpatients with COVID-19” issued by the Ministry of Health and Medical Education of Iran.
Materials & Methods: Psychiatric counseling was requested for 109 adult COVID-19 patients with anxiety admitted to a hospital in Tehran City, Iran.
Results: About 59.6% of patients were female, and their mean age was 55.9 years. In 55 patients, anxiety was due to the symptoms and complications of COVID-19. The relative frequency of the causes of anxiety were as follows: Delirium (11.9%), new respiratory distress (2.8%), oxygen saturation between 85 to 90(3.7%), severe and moderate pain (5.5%), fever and chills (13.7%), cough (0.9%), and nausea and vomiting (11.9%). Anxiety in four patients (3.7%) was caused by smoking and opium withdrawal syndrome. In 50 other patients, no medical cause was found, and oxygen-saturated biofeedback training was used to manage patients (n=22) in mild to moderate anxiety cases. In cases of severe anxiety, a short-acting benzodiazepine was used in patients without a history of psychiatry (n=18) and a combination of selective serotonin reuptake inhibitors and a benzodiazepine in patients (n=10) with a history of psychiatric disorders. The most common comorbidities were diabetes and major depressive disorder (18.3% and 4.58%, respectively).
Conclusion: Though in the majority of cases, anxiety was caused by the direct effects or complications of COVID-19, appropriate intervention to manage the underlying factors can reduce the need for psychiatric medications. 

Full-Text [PDF 579 kb]   (31 Downloads) |   |   Full-Text (HTML)  (7 Views)  
Type of Study: Applicable | Subject: Psychology
Received: 2023/03/18 | Accepted: 2023/12/22 | Published: 2024/04/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 All Rights Reserved | Current Psychosomatic Research

Designed & Developed by : Yektaweb